NeuroPace, Inc.
NPCE
$11.25
$0.1050.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 79.91M | 76.45M | 71.82M | 69.07M | 65.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.91M | 76.45M | 71.82M | 69.07M | 65.42M |
| Cost of Revenue | 20.82M | 20.01M | 18.56M | 17.98M | 17.30M |
| Gross Profit | 59.09M | 56.44M | 53.26M | 51.09M | 48.12M |
| SG&A Expenses | 57.10M | 56.53M | 56.01M | 56.19M | 54.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.58M | 99.52M | 96.60M | 95.47M | 92.60M |
| Operating Income | -21.67M | -23.07M | -24.78M | -26.40M | -27.17M |
| Income Before Tax | -27.14M | -28.09M | -29.90M | -31.51M | -32.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.14 | -28.09 | -29.90 | -31.51 | -32.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.14M | -28.09M | -29.90M | -31.51M | -32.96M |
| EBIT | -21.67M | -23.07M | -24.78M | -26.40M | -27.17M |
| EBITDA | -21.46M | -22.87M | -24.60M | -26.23M | -27.00M |
| EPS Basic | -0.94 | -0.99 | -1.09 | -1.18 | -1.28 |
| Normalized Basic EPS | -0.59 | -0.61 | -0.67 | -0.73 | -0.79 |
| EPS Diluted | -0.94 | -1.00 | -1.09 | -1.19 | -1.28 |
| Normalized Diluted EPS | -0.59 | -0.61 | -0.67 | -0.73 | -0.79 |
| Average Basic Shares Outstanding | 116.50M | 113.38M | 109.96M | 106.57M | 103.39M |
| Average Diluted Shares Outstanding | 116.50M | 113.38M | 109.96M | 106.57M | 103.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |